Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe-Reference-Cited by-同舟云学术

Effectiveness of integrase strand transfer inhibitors in HIV‐infected treatment‐experienced individuals across Europe

Published:2022-02-24 Issue:7 Volume:23 Page:774-789
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Medicine

Author:

Rossetti Barbara¹^ORCID,Fabbiani Massimiliano¹^ORCID,Di Carlo Domenico²,Incardona Francesca³⁴,Abecasis Ana⁵,Gomes Perpetua⁶⁷,Geretti Anna Maria⁸⁹,Seguin‐Devaux Carole¹⁰,Garcia Federico¹¹¹²¹³^ORCID,Kaiser Rolf¹⁴,Modica Sara¹^ORCID,Shallvari Adrian⁴,Sönnerborg Anders¹⁵,Zazzi Maurizio¹⁶,Abecasis A.,Bobkova M.,Seguin‐Devaux C.,Fabbiani M.,Garcia F.,Geretti A. M.,Gomes P.,Incardona F.,Kaiser R.,Paredes R.,Rossetti B.,Sayan M.,Sönnerborg A.,Vandamme A. M.,Zazzi M.,

Affiliation:

1. Infectious Diseases Unit University Hospital of Siena Siena Italy

2. University of Milan “La Statale” Milano Italy

3. EuResist Network Rome Italy

4. I‐PRO Rome Italy

5. Global Health and Tropical Medicine (GHTM) Instituto de Higiene e Medicina Tropical ‐ Universidade Nova de Lisboa Lisbon Portugal

6. Laboratório de Biologia Molecular (LMCBM, SPC, CHLO‐HEM) Lisbon Portugal

7. Centro de Investigação Interdisciplinar Egas Moniz (CiiEM) Instituto Universitário Egas Moniz Caparica Portugal

8. Department of Infectious Disease University of Rome Tor Vergata Rome Italy

9. Department of Infectious Diseases King's College London London UK

10. Department of Infection and Immunity Luxembourg Institute of Health Esch‐sur‐Alzette Luxembourg

11. Hospital Universitario San Cecilio Granada Spain

12. Instituto de Investigación IBS. Granada Spain

13. Ciber de Enfermedades Infecciosas CIBERINFEC ISCIII Madrid Spain

14. University of Cologne Cologne Germany

15. Karolinska Institutet Stockholm Sweden

16. University of Siena Siena Italy

Funder

Stockholms Läns Landsting

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13262

Reference50 articles.

1. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

2. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

3. Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe

4. EACS.EACS Guidelines Version 10.0. 2019.http://www.eacsociety.org/files/2019_guidelines‐10.0‐english.pdf. Accessed October 1 2020.

5. Updated recommendations on first‐line and second‐line antiretroviral regimens and post‐exposure prophylaxis and recommendations on early infant diagnosis of HIV World Health Organization; 2018.https://www.who.int/hiv/pub/guidelines/ARV2018update/en/. Accessed October 1 2020.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal;Viruses;2024-04-17

2. Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV;Journal of Clinical Medicine;2023-12-18

3. Modeling UNAIDS treatment targets for China;AIDS;2023-06-01

4. Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network);Tropical Medicine and Infectious Disease;2023-04-23

5. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study;The Lancet HIV;2023-04